- Emerson Electric Co (NYSE:EMR) is reportedly in advanced talks to acquire National Instruments Corp (NASDAQ:NATI) after a long quest for the maker of measurement systems.
- Emerson is negotiating for $60 a share for the deal, which could value NATI at about $8 billion, Reuters reported citing familiar sources.
- Emerson beat out rival Fortive Corp (NYSE:FTV) and Keysight Technologies Inc (NYSE:KEYS) in the run for National Instruments.
- Following the announcement of Emerson’s interest in National Instruments in January, Reuters reported in March that Emerson, Fortive, and Keysight had advanced to the final round of bidding for the company.
- Related: Emerson Discloses $7.6B Offer For National Instruments – Reveals Several Private Attempts Made Over Last Eight Months
- Emerson had threatened to challenge National Instruments’ board of directors if it did not engage in deal negotiations in January, prompting the company to launch a formal sale process.
- Emerson Electric held cash and equivalents of $2.27 billion as of Dec. 31, 2022.
- Price Action: EMR shares are trading lower by 1.71% at $83.00 and NATI higher by 8.62% at $57.11 premarket on Wednesday.
Biodexa Announces $7M Of Gross Proceeds From Warrant Exercises And An Agreement Between The Company And Several Accredited Investors To Exercise Certain Existing Series E Warrants And Series F Warrants To Purchase Up To An Aggregate Of 4,358,322 ADSs
Biodexa Announces $7 Million of Gross Proceeds from Warrant ExercisesProceeds Cover Year 1 eRapa Phase 3 Obligations, Unlocking Twice that Amount in Non-dilutive Grant FundingBiodexa Pharmaceuticals PLC, (NASDAQ:BDRX),
